Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-I (Part-II)

M
Ms. Pooja BhandareAssistant Professor
Pharmaceutical Inorganic chemistry
UNIT-I (Part-II)
Types and Sources of impurities
Presented By
Ms. Pooja D. Bhandare
(Assistant Professor)
DADASAHEB BALPANDE COLLEGE OF PHARMACY BESA NAGPUR
• Impure Chemical Compound: A compound is said to be impure if it is having
foreign matter i.e Impurities.
• Pure Chemical Compound: A pure chemical compound refers to that compound
which is having no foreign matter.
• Chemical purity means freedom from foreign matter.
• Analytically 100 % pure substances are not available and traces of impurities must
be present.
• Normally undesirable foreign materials are present in the pharmaceutical
substances.
Impurities:
• Impurity is any material that affects the purity of the material of interest.
• Presence of Impurities in the pharmaceutical substances may produce
toxic effects on the body and may also lower down the active strength of
the pharmaceutical substance.
• Impurities commonly in chemical substances include small quantities of
lead, Arsenic, Iron , Chloride and sulphate.
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-I (Part-II)
 Sources of Impurities in Pharmaceuticals
• The different sources of impurities in pharmaceuticals are listed below:
1) Raw material used in manufacture
2) Reagents used in manufacturing process
3) Method/ process used in manufacture or method of manufacturing
4) Chemical processes used in the manufacture
5) Atmospheric contamination during the manufacturing process
6) Intermediate products in the manufacturing process
7) Defects in the manufacturing process
8) Manufacturing hazards
9) Inadequate Storage conditions
10) Decomposition of the product during storage
11) Accidental substitution or deliberate adulteration with spurious or useless materials
1)Raw materials employed in manufacture
• Impurities known to be associated with these chemicals may be carried through
the manufacturing process and contaminate the final product. • Example
• Rock salt--------→
Calcium Sulphate (CaSO4 ) + Magnesium Chloride (MgCl2 )= NaCl prepared
• Rock salt contains small amounts of Calcium sulphate and Magnesium chloride.
Thus Sodium chloride prepared from this source will contain traces of Calcium
and Magnesium compounds.
• Impurities such as Arsenic, Lead and Heavy metals are present in raw materials
and hence are found in substances. So, it is necessary to use pure chemicals and
substances as raw materials for the manufacturing process.
• Example:
• Copper sulphate may be prepared by the action of sulphuric acid on copper turnings:
Cu+ 2 H2SO4 ------------------------→ CuSO4 + 2 H2O + SO2
• Copper turnings are known to have Iron and Arsenic asimpurities. If Large quantities
of impurities are present in the raw material (e.g Copper turnings), they may enter the
final product. (CuSO4 .5H2O)
• Due to this I.P. prescribes limit of tolerance for Arsenic as impurity to be not more
than 8 parts per million in copper sulphate. Similarly it prescribes a limit of Iron as
impurity.
2) Reagents used in the manufacturing process:
• If reagents used in the manufacturing process are not completely removed by washing,
these may find entry into the final products.
• Example: Ammoniated mercury may be prepared by adding a solution of Mercuric chloride
to dilute ammonia solution.
HgCl2+ 2NH4OH-------------→NH2HgCl + NH4Cl + 2 H2O
• The precipitate of Ammoniated mercury (Final Product)contains ammonium hydroxide.
• Thus, this precipitate is washed with cold water to remove ammonium hydroxide. If it is not
removed completely by washing with water, the final product may contain in it Ammonium
hydroxide as impurity.
3) Method or the process used in the manufacture:
• Many drugs and chemicals (usually organic) are manufactured from different
raw materials, by using different methods or processes
• Some impurities are incorporated into the materials during the manufacturing
process.
• The type and amount of impurity present in the drug/ chemical varies.
• In certain drugs a multiple step synthesis procedure is used which produces
intermediate compounds
• The purification of intermediates is also important, otherwise the impurities
present in the intermediate will get incorporated in the final product
• Usually side reactions occur during the synthesis.
• Impurities of the product side reactions also occur in the substances This
may
• introduce new impurities due to contamination by reagents and solvents at
various
• stages of the process as described below
a)Reagents employed in the process
b)Reagents added to remove other impurities
c)Solvents
d)Action of solvents and reagents on reaction vessels
a)Reagents employed in the manufacturing process:
• Soluble alkali in Calcium carbonate arises from sodium carbonate used in the
process.
• Calcium carbonate is obtained by interaction of a soluble calcium salt and a
soluble carbonate and therefore the product will contain traces of soluble
alkali, which the washing process has failed to remove.
b) Reagents added to remove other impurities:
•Potassium bromide contains traces of Barium, which is added in the
manufacturing process to remove excess of sulphate.
C) Solvents: Water is the cheapest solvent available and has been used wherever
possible.
• Tap Water: It has Ca+2, Mg+2, Na+, Cl-, SO4 -2 and CO3 -2 as impurities in
small amounts. Hence even if good deal of washing of final product is done by
tap water the final product may still contain traces of such impurities.
• Softened water: It is obtained by allowing the tap water to pass through the
sodium form of Zeolite which removes divalent cations like Ca+2 and Mg+2
from tap water in exchange of sodium. So, softened water contains Na+, Cl-
ions as impurity.
• De-mineralised water: It is obtained by passing tap water through columns
packed with ion exchange resin. The water obtained from this process is free
from Ca+2, Mg+2, Na+, Cl-, SO4 -2 and CO3-2. Thus the final product is free
from these impurities. The water obtained from this source may still contain
organic impurities and so final product contains organic impurities.
• Distilled water: It is considered the best but it is very costly.
d) Action of solvents and reagents on reaction vessels:
• During manufacturing process, some of the solvents and reagent may undergo
reaction with metals of reaction vessel and may dissolve these metals, which appear
as impurities in the final product.
• Example:
Iron is known to contain Arsenic impurity.
• The inorganic compounds manufactured in Iron vessel will contain Arsenic and Iron
as impurities.
• Thus IP has prescribed limit test for Arsenic and Iron for most inorganic compounds.
4) Chemical process used in the manufacture:
For the synthesis of drugs, many chemical reactions such as Nitration, Halogenation,
Oxidation, reduction, hydrolysis are involved.
• In these chemical processes, different chemicals are used.
• Tap water is generally used in the various processes and it is often having Cl-,Mg+2,
Ca+2 ions, which are generally found in the substance which is being manufactured
and limit of these impurities have been prescribed in large number of cases. For
instance, potassium iodide is manufactured from iodine which is obtained from ‘kelp,
a seaweed cyanides tend to get formed when nitrogenous organic matter is burnt with
alkalies. Limit tests have been prescribed for cyanides in potassium iodide.
5) Atmospheric contamination during the manufacturing
process
• In the industrial areas, the atmosphere is contaminated with dust particles
and some gases like Hydrogen sulphide, Sulphur dioxide, and black
smoke.
• During the manufacture or purification of the pharmaceutical products,
these impurities enter the final products.
• There are many pharmaceutical products which when manufactured are
contaminated with atmospheric CO2 and water vapour .E.g NaOH absorbs
atmospheric CO2.
2NaOH + CO2 --------------------------------Na2CO3 +H2O
• Due to this reaction, NaOH should not be kept open for a longer time
during its manufacture.
• Therefore, IP has prescribed that Sodium hydroxide should not contain
more than 3% of sodium carbonate.
6) Defects in the manufacturing process:
• In many manufacturing processes, there are defects like imperfect mixing,
incompleteness, non-adherence to proper temperature, pressure, pH or
reaction conditions, which may give chemical compounds with impurities
in them.
Example:
• Zinc oxide may be prepared by heating metallic zinc to bright redness in a
current of air. The vapours of Zinc burn to form Zinc oxide which is
collected as a fine white powder.
• But if there is less heat or air or both, zinc metal is not completely
converted to zinc oxide.
• Thus the final product, Zinc oxide may still contain metallic zinc as
impurity.
• So, IP has prescribed a test for Zinc metal in zinc oxide.
7) Intermediate products in the manufacturing
process:
• There are some intermediates which are produced during the manufacturing
process.
• Sometimes these intermediates may be carried through to the final product as
impurity.
• Example:
• Potassium iodide is prepared by reacting Iodine with Potassium hydroxide.
6KOH+ 3I2--------------------5KI + KIO3 +3H2O
• The resulting solution is first evaporated and then heated with charcoal.
KIO3 +3C----------KI +3CO
• In this process if the intermediate product (KIO3) is not completely converted
into KI, then it may be carried through to the final product as an impurity.
8) Manufacturing hazards:
Particulate
contamination
Process errors
Cross
contamination
Microbial
contamination
Packing error
a) Particulate contamination:
• The presence of unwanted particulate matter can arise due to dirt, dust,
glass, porcelain or plastic fragments from sieves, granulating or
tableting machines or from product containers.
• Ware and tare of equipment or improperly cleaned equipment may
also cause particulate contamination.
• Clarity of solutions for injection is particularly important.
• E.g Metal particles which have been found in eye ointments packed in
metal tubes.
b) Process errors:
• Gross errors arising from incomplete solution of a solute in a liquid
preparation must be detected readily by the normal analytical control
procedures.
• Minor errors arise if the manufacturing tolerance for the quantity of active
ingredient in the product has been wide.
c) Cross contamination:
• The handling of powders, granules, and tablets in large bulk creates air-
borne dust, which leads to cross contamination of theproduct.
• So, face masks and special extraction equipment are used to protect
operators from harmful effects of drugs.
• E.g penicillin preparation requires special handling during itsmanufacture.
d) Microbial contamination:
• Parenteral preparations and ophthalmic preparations require special care
against
microbial contamination.
• Many liquid preparations and creams are liable to bacterial and fungal
contamination. So care should betaken.
• Eg. Acacia, senna, tragacanth---
They should be controlled for Salmonellae.
e) Packing errors:
• Products of similar appearance such as tablets of same size, shape, colour
packed in similar containers can constitute a potential source of danger.
• Improper labelling or destruction of stock of unused labels also constitutes
a major packaging hazard.
9) Storage conditions:
• The chemical substances when prepared have to be stored in different types of
containers depending upon:
• Nature of the material
• Batch size
• Quantity
• Many types of materials are used for storage purpose like plastic, polythene,
iron vessels, stainless steel and aluminium.
Reaction of these substance + with material of storage vessels-------- The product
are found as impurity in stored material.
• Leaching out effect: Alkalies stored in ordinary glass containers extract
lead from it, which in found as impurity in the final product.
• Strong chemicals react with iron containers and extract Iron an impurity
in final product.
Inadequate storage and their effects are as follows:
a)Filth: Stored products may be come contaminated with dust, bodies of insects,
animal and insect excreta.
b)Chemical instability: decomposition because of light, traces of acid or alkali,
air oxidation, water vapour,CO2 and traces of metallic ions.
e.g light sensitive materials should be stored in amber colored bottles.
c)Reactions with container materials: e.g salicylic acid ointment must not be
stored in metal tubes.
d)Physical changes: The occurance of changes in the physical form of drug like
change in crystal size can lead to change in efficiency ofproduct.
e)Temperature effect: Chemical and physical changes occur if materials are not
stored at proper temperature.
10) Decomposition of the product during storage:
• Some substances decompose on keeping. The decomposition becomes greater in the
presence of light-air or oxygen. The result of decomposition bring about contamination
of the final product.
• Substances which contain water of crystallization lose it on being kept open while
deliquescent substances, absorb water from the atmosphere and get liquefied.
• Decomposition products appear as impurities in the substances.
11) Accidental substitution or deliberate
adulteration with spurious or use less materials:
• It is possible to avoid accidental substitution by storing the toxic substances
together
• Separately or in a locked cupboard.
• Many pharmaceutical chemicals are adulterated with cheaper substances.
• E.g The expensive potassium may be adulterated with sodium bromide.
Effect of Impurities:
• The impurities present in the substances may give following effects:
• Impurities having toxic effects may be injurious to health, if present above Certain limits.
• Traces of impurities, may exert a cumulative toxic effect after a certain time.
• Impurities may lower the active strength of the substance.
• Impurity may decrease shelf life of substance.
• Impurity may cause incompatibility with other substances.
• Impurities may cause a physical or chemical change in the properties of the substance, so making the substance
medicinally useless.
• May cause change in color, odour and taste.
 Test for purity:
Pharmacopoeia prescribes the “Test for purity” for pharmaceutical substances to check their freedom
from undesirable impurities.
Pharmacopoeia will decide and fix the limit of tolerance for these impurities.
For certain common impurities for which pharmacopoeia prescribes the test of purity are:
Colour, odour, taste
Physicochemical constants (Iodine value, saponification value, melting point, refractive index etc.)
Acidity, alkalinity, pH
Humidity (Estimation of moisture)
Cations and anions
Insoluble Constituent or Residue.
Ash, Water insoluble ash
Arsenic or lead
Loss on drying
Loss on ignition
Thank You !
1 de 31

Recomendados

Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx por
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptxIntroduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptxMs. Pooja Bhandare
1K vistas30 diapositivas
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx por
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptxGastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptxMs. Pooja Bhandare
1.1K vistas59 diapositivas
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr... por
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...Ms. Pooja Bhandare
778 vistas51 diapositivas
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test por
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit TestLimt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit TestMs. Pooja Bhandare
1.8K vistas47 diapositivas
Dental products.pptx por
Dental products.pptxDental products.pptx
Dental products.pptxMs. Pooja Bhandare
553 vistas28 diapositivas
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant... por
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...Ms. Pooja Bhandare
231 vistas45 diapositivas

Más contenido relacionado

La actualidad más candente

DENTAL PRODUCTS por
DENTAL PRODUCTS DENTAL PRODUCTS
DENTAL PRODUCTS Sayali Powar
3.9K vistas43 diapositivas
3.limit test for sulphate por
3.limit test for sulphate3.limit test for sulphate
3.limit test for sulphateDR.Gopinathan Narasimhan
70.1K vistas19 diapositivas
Limit test for chlorides alok sharma por
Limit test for chlorides  alok sharmaLimit test for chlorides  alok sharma
Limit test for chlorides alok sharmaaaaaalok
11.9K vistas11 diapositivas
Amonium chloride por
Amonium chlorideAmonium chloride
Amonium chlorideZainab&Sons
6.1K vistas13 diapositivas
Major extracellular and intracellular electrolytes por
Major extracellular and intracellular electrolytesMajor extracellular and intracellular electrolytes
Major extracellular and intracellular electrolytesRevathi Gnanavelou
1.1K vistas53 diapositivas
Major intra and extracellular electrolytes por
Major intra and extracellular electrolytesMajor intra and extracellular electrolytes
Major intra and extracellular electrolytesabhishek rai
3.1K vistas39 diapositivas

La actualidad más candente(20)

DENTAL PRODUCTS por Sayali Powar
DENTAL PRODUCTS DENTAL PRODUCTS
DENTAL PRODUCTS
Sayali Powar3.9K vistas
Limit test for chlorides alok sharma por aaaaalok
Limit test for chlorides  alok sharmaLimit test for chlorides  alok sharma
Limit test for chlorides alok sharma
aaaaalok11.9K vistas
Amonium chloride por Zainab&Sons
Amonium chlorideAmonium chloride
Amonium chloride
Zainab&Sons6.1K vistas
Major extracellular and intracellular electrolytes por Revathi Gnanavelou
Major extracellular and intracellular electrolytesMajor extracellular and intracellular electrolytes
Major extracellular and intracellular electrolytes
Revathi Gnanavelou1.1K vistas
Major intra and extracellular electrolytes por abhishek rai
Major intra and extracellular electrolytesMajor intra and extracellular electrolytes
Major intra and extracellular electrolytes
abhishek rai3.1K vistas
Limit test of Arsenic por Sonali Pawar
Limit test of ArsenicLimit test of Arsenic
Limit test of Arsenic
Sonali Pawar13.2K vistas
limit test for chloride por TAUFIK MULLA
limit test for chloridelimit test for chloride
limit test for chloride
TAUFIK MULLA3.3K vistas
limit test for lead por TAUFIK MULLA
limit test for leadlimit test for lead
limit test for lead
TAUFIK MULLA2.7K vistas
Limit test of Arsenic por gaurav gautam
Limit test of Arsenic Limit test of Arsenic
Limit test of Arsenic
gaurav gautam7.8K vistas
Impurities in pharmaceutical substances por ShaliniBarad
Impurities in pharmaceutical substancesImpurities in pharmaceutical substances
Impurities in pharmaceutical substances
ShaliniBarad2.2K vistas
Sources and types of impurities por jagan vana
Sources and types of impuritiesSources and types of impurities
Sources and types of impurities
jagan vana7.1K vistas
limit test for arsenic por TAUFIK MULLA
limit test for arseniclimit test for arsenic
limit test for arsenic
TAUFIK MULLA2K vistas

Similar a Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-I (Part-II)

Pharmaceutical impurities por
Pharmaceutical impuritiesPharmaceutical impurities
Pharmaceutical impuritiesMahima Dubey
971 vistas18 diapositivas
Sources-of-Impurities-.pdf por
Sources-of-Impurities-.pdfSources-of-Impurities-.pdf
Sources-of-Impurities-.pdfSivaPoornima1
36 vistas25 diapositivas
Sources-of-Impurities-. PPT por
Sources-of-Impurities-. PPT Sources-of-Impurities-. PPT
Sources-of-Impurities-. PPT ManmathanV
28 vistas25 diapositivas
Impurites por
Impurites Impurites
Impurites shinganaarti
547 vistas30 diapositivas
2.Impurities (2) (4).pptx por
2.Impurities (2) (4).pptx2.Impurities (2) (4).pptx
2.Impurities (2) (4).pptxManishKumar253026
40 vistas112 diapositivas
sources of impurities.pptx por
sources of impurities.pptxsources of impurities.pptx
sources of impurities.pptxPoonam Aher Patil
15 vistas20 diapositivas

Similar a Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-I (Part-II)(20)

Pharmaceutical impurities por Mahima Dubey
Pharmaceutical impuritiesPharmaceutical impurities
Pharmaceutical impurities
Mahima Dubey971 vistas
Sources-of-Impurities-.pdf por SivaPoornima1
Sources-of-Impurities-.pdfSources-of-Impurities-.pdf
Sources-of-Impurities-.pdf
SivaPoornima136 vistas
Sources-of-Impurities-. PPT por ManmathanV
Sources-of-Impurities-. PPT Sources-of-Impurities-. PPT
Sources-of-Impurities-. PPT
ManmathanV28 vistas
Impurities and their limit test por ESHA SHAH
Impurities and their limit testImpurities and their limit test
Impurities and their limit test
ESHA SHAH130.6K vistas
Quality control drugs and pharmaceuticals por SHIVANEE VYAS
Quality control drugs and pharmaceuticalsQuality control drugs and pharmaceuticals
Quality control drugs and pharmaceuticals
SHIVANEE VYAS638 vistas
Cosmetic industry por Dipo Elegbs
Cosmetic industryCosmetic industry
Cosmetic industry
Dipo Elegbs7.6K vistas
sugar industry.pptx por JadavChirag3
sugar industry.pptxsugar industry.pptx
sugar industry.pptx
JadavChirag3252 vistas
Impurity (effect and sources) por TAUFIK MULLA
Impurity (effect and sources)Impurity (effect and sources)
Impurity (effect and sources)
TAUFIK MULLA209 vistas
Study of wastewater characterstics por DhruvSharma305
Study of wastewater charactersticsStudy of wastewater characterstics
Study of wastewater characterstics
DhruvSharma30594 vistas

Más de Ms. Pooja Bhandare

Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx por
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptxPharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptxMs. Pooja Bhandare
207 vistas51 diapositivas
Polyploidy, mutation and hybridization with reference to medicinal plants. PH... por
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...Ms. Pooja Bhandare
1.4K vistas46 diapositivas
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem... por
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...Ms. Pooja Bhandare
184 vistas28 diapositivas
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni... por
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni...Ms. Pooja Bhandare
1.1K vistas27 diapositivas
Cultivation and collections of drugs of natural origin..pptx por
Cultivation and collections of drugs of natural origin..pptxCultivation and collections of drugs of natural origin..pptx
Cultivation and collections of drugs of natural origin..pptxMs. Pooja Bhandare
828 vistas33 diapositivas
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ... por
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...Ms. Pooja Bhandare
2.5K vistas41 diapositivas

Más de Ms. Pooja Bhandare(20)

Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx por Ms. Pooja Bhandare
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptxPharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Ms. Pooja Bhandare207 vistas
Polyploidy, mutation and hybridization with reference to medicinal plants. PH... por Ms. Pooja Bhandare
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Ms. Pooja Bhandare1.4K vistas
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem... por Ms. Pooja Bhandare
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Ms. Pooja Bhandare184 vistas
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni... por Ms. Pooja Bhandare
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni...
Ms. Pooja Bhandare1.1K vistas
Cultivation and collections of drugs of natural origin..pptx por Ms. Pooja Bhandare
Cultivation and collections of drugs of natural origin..pptxCultivation and collections of drugs of natural origin..pptx
Cultivation and collections of drugs of natural origin..pptx
Ms. Pooja Bhandare828 vistas
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ... por Ms. Pooja Bhandare
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Ms. Pooja Bhandare2.5K vistas
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I... por Ms. Pooja Bhandare
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Ms. Pooja Bhandare283 vistas
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx por Ms. Pooja Bhandare
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptxPharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Ms. Pooja Bhandare825 vistas
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5 por Ms. Pooja Bhandare
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Ms. Pooja Bhandare3.1K vistas
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB... por Ms. Pooja Bhandare
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Ms. Pooja Bhandare890 vistas
Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU... por Ms. Pooja Bhandare
Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...
Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...
Ms. Pooja Bhandare3.7K vistas
Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO... por Ms. Pooja Bhandare
Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...
Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...
Ms. Pooja Bhandare2.7K vistas
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical... por Ms. Pooja Bhandare
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Ms. Pooja Bhandare9.1K vistas
Microbiological Assay of Vitamin & Amino acid Assessment of a New Antibiotic... por Ms. Pooja Bhandare
Microbiological Assay of  Vitamin & Amino acid Assessment of a New Antibiotic...Microbiological Assay of  Vitamin & Amino acid Assessment of a New Antibiotic...
Microbiological Assay of Vitamin & Amino acid Assessment of a New Antibiotic...
Ms. Pooja Bhandare4.9K vistas
Principles and methods of different microbiological assay, methods for standa... por Ms. Pooja Bhandare
Principles and methods of different microbiological assay, methods for standa...Principles and methods of different microbiological assay, methods for standa...
Principles and methods of different microbiological assay, methods for standa...
Ms. Pooja Bhandare5.5K vistas
Designing of aseptic area, laminar flow equipment: Study of different source ... por Ms. Pooja Bhandare
Designing of aseptic area, laminar flow equipment: Study of different source ...Designing of aseptic area, laminar flow equipment: Study of different source ...
Designing of aseptic area, laminar flow equipment: Study of different source ...
Ms. Pooja Bhandare3.4K vistas
Sterility testing products (solids, liquids, ophthalmic and other sterile pro... por Ms. Pooja Bhandare
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Ms. Pooja Bhandare6.9K vistas
Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ... por Ms. Pooja Bhandare
Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...
Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...
Ms. Pooja Bhandare4K vistas
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant... por Ms. Pooja Bhandare
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Ms. Pooja Bhandare4.4K vistas
Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG... por Ms. Pooja Bhandare
Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...
Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...
Ms. Pooja Bhandare10.6K vistas

Último

GSoC 2024 .pdf por
GSoC 2024 .pdfGSoC 2024 .pdf
GSoC 2024 .pdfShabNaz2
45 vistas15 diapositivas
Creative Restart 2023: Christophe Wechsler - From the Inside Out: Cultivating... por
Creative Restart 2023: Christophe Wechsler - From the Inside Out: Cultivating...Creative Restart 2023: Christophe Wechsler - From the Inside Out: Cultivating...
Creative Restart 2023: Christophe Wechsler - From the Inside Out: Cultivating...Taste
39 vistas34 diapositivas
Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf por
 Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf
Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdfTechSoup
67 vistas28 diapositivas
STRATEGIC MANAGEMENT MODULE 1_UNIT1 _UNIT2.pdf por
STRATEGIC MANAGEMENT MODULE 1_UNIT1 _UNIT2.pdfSTRATEGIC MANAGEMENT MODULE 1_UNIT1 _UNIT2.pdf
STRATEGIC MANAGEMENT MODULE 1_UNIT1 _UNIT2.pdfDr Vijay Vishwakarma
136 vistas68 diapositivas
Introduction to AERO Supply Chain - #BEAERO Trainning program por
Introduction to AERO Supply Chain  - #BEAERO Trainning programIntroduction to AERO Supply Chain  - #BEAERO Trainning program
Introduction to AERO Supply Chain - #BEAERO Trainning programGuennoun Wajih
135 vistas78 diapositivas
ICS3211_lecture 09_2023.pdf por
ICS3211_lecture 09_2023.pdfICS3211_lecture 09_2023.pdf
ICS3211_lecture 09_2023.pdfVanessa Camilleri
150 vistas10 diapositivas

Último(20)

GSoC 2024 .pdf por ShabNaz2
GSoC 2024 .pdfGSoC 2024 .pdf
GSoC 2024 .pdf
ShabNaz245 vistas
Creative Restart 2023: Christophe Wechsler - From the Inside Out: Cultivating... por Taste
Creative Restart 2023: Christophe Wechsler - From the Inside Out: Cultivating...Creative Restart 2023: Christophe Wechsler - From the Inside Out: Cultivating...
Creative Restart 2023: Christophe Wechsler - From the Inside Out: Cultivating...
Taste39 vistas
Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf por TechSoup
 Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf
Ask The Expert! Nonprofit Website Tools, Tips, and Technology.pdf
TechSoup 67 vistas
Introduction to AERO Supply Chain - #BEAERO Trainning program por Guennoun Wajih
Introduction to AERO Supply Chain  - #BEAERO Trainning programIntroduction to AERO Supply Chain  - #BEAERO Trainning program
Introduction to AERO Supply Chain - #BEAERO Trainning program
Guennoun Wajih135 vistas
UNIT NO 13 ORGANISMS AND POPULATION.pptx por Madhuri Bhande
UNIT NO 13 ORGANISMS AND POPULATION.pptxUNIT NO 13 ORGANISMS AND POPULATION.pptx
UNIT NO 13 ORGANISMS AND POPULATION.pptx
Madhuri Bhande48 vistas
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE... por Nguyen Thanh Tu Collection
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...
BÀI TẬP BỔ TRỢ TIẾNG ANH 11 THEO ĐƠN VỊ BÀI HỌC - CẢ NĂM - CÓ FILE NGHE (FRIE...
JRN 362 - Lecture Twenty-Three (Epilogue) por Rich Hanley
JRN 362 - Lecture Twenty-Three (Epilogue)JRN 362 - Lecture Twenty-Three (Epilogue)
JRN 362 - Lecture Twenty-Three (Epilogue)
Rich Hanley44 vistas
Education of marginalized and socially disadvantages segments.pptx por GarimaBhati5
Education of marginalized and socially disadvantages segments.pptxEducation of marginalized and socially disadvantages segments.pptx
Education of marginalized and socially disadvantages segments.pptx
GarimaBhati552 vistas
JQUERY.pdf por ArthyR3
JQUERY.pdfJQUERY.pdf
JQUERY.pdf
ArthyR3114 vistas
Peripheral artery diseases by Dr. Garvit.pptx por garvitnanecha
Peripheral artery diseases by Dr. Garvit.pptxPeripheral artery diseases by Dr. Garvit.pptx
Peripheral artery diseases by Dr. Garvit.pptx
garvitnanecha135 vistas
Guidelines & Identification of Early Sepsis DR. NN CHAVAN 02122023.pptx por Niranjan Chavan
Guidelines & Identification of Early Sepsis DR. NN CHAVAN 02122023.pptxGuidelines & Identification of Early Sepsis DR. NN CHAVAN 02122023.pptx
Guidelines & Identification of Early Sepsis DR. NN CHAVAN 02122023.pptx
Niranjan Chavan43 vistas
Presentation_NC_Future now 2006.pdf por Lora
Presentation_NC_Future now 2006.pdfPresentation_NC_Future now 2006.pdf
Presentation_NC_Future now 2006.pdf
Lora 38 vistas

Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-I (Part-II)

  • 1. Pharmaceutical Inorganic chemistry UNIT-I (Part-II) Types and Sources of impurities Presented By Ms. Pooja D. Bhandare (Assistant Professor) DADASAHEB BALPANDE COLLEGE OF PHARMACY BESA NAGPUR
  • 2. • Impure Chemical Compound: A compound is said to be impure if it is having foreign matter i.e Impurities. • Pure Chemical Compound: A pure chemical compound refers to that compound which is having no foreign matter. • Chemical purity means freedom from foreign matter. • Analytically 100 % pure substances are not available and traces of impurities must be present. • Normally undesirable foreign materials are present in the pharmaceutical substances. Impurities:
  • 3. • Impurity is any material that affects the purity of the material of interest. • Presence of Impurities in the pharmaceutical substances may produce toxic effects on the body and may also lower down the active strength of the pharmaceutical substance. • Impurities commonly in chemical substances include small quantities of lead, Arsenic, Iron , Chloride and sulphate.
  • 5.  Sources of Impurities in Pharmaceuticals • The different sources of impurities in pharmaceuticals are listed below: 1) Raw material used in manufacture 2) Reagents used in manufacturing process 3) Method/ process used in manufacture or method of manufacturing 4) Chemical processes used in the manufacture 5) Atmospheric contamination during the manufacturing process 6) Intermediate products in the manufacturing process 7) Defects in the manufacturing process 8) Manufacturing hazards 9) Inadequate Storage conditions 10) Decomposition of the product during storage 11) Accidental substitution or deliberate adulteration with spurious or useless materials
  • 6. 1)Raw materials employed in manufacture • Impurities known to be associated with these chemicals may be carried through the manufacturing process and contaminate the final product. • Example • Rock salt--------→ Calcium Sulphate (CaSO4 ) + Magnesium Chloride (MgCl2 )= NaCl prepared • Rock salt contains small amounts of Calcium sulphate and Magnesium chloride. Thus Sodium chloride prepared from this source will contain traces of Calcium and Magnesium compounds. • Impurities such as Arsenic, Lead and Heavy metals are present in raw materials and hence are found in substances. So, it is necessary to use pure chemicals and substances as raw materials for the manufacturing process.
  • 7. • Example: • Copper sulphate may be prepared by the action of sulphuric acid on copper turnings: Cu+ 2 H2SO4 ------------------------→ CuSO4 + 2 H2O + SO2 • Copper turnings are known to have Iron and Arsenic asimpurities. If Large quantities of impurities are present in the raw material (e.g Copper turnings), they may enter the final product. (CuSO4 .5H2O) • Due to this I.P. prescribes limit of tolerance for Arsenic as impurity to be not more than 8 parts per million in copper sulphate. Similarly it prescribes a limit of Iron as impurity.
  • 8. 2) Reagents used in the manufacturing process: • If reagents used in the manufacturing process are not completely removed by washing, these may find entry into the final products. • Example: Ammoniated mercury may be prepared by adding a solution of Mercuric chloride to dilute ammonia solution. HgCl2+ 2NH4OH-------------→NH2HgCl + NH4Cl + 2 H2O • The precipitate of Ammoniated mercury (Final Product)contains ammonium hydroxide. • Thus, this precipitate is washed with cold water to remove ammonium hydroxide. If it is not removed completely by washing with water, the final product may contain in it Ammonium hydroxide as impurity.
  • 9. 3) Method or the process used in the manufacture: • Many drugs and chemicals (usually organic) are manufactured from different raw materials, by using different methods or processes • Some impurities are incorporated into the materials during the manufacturing process. • The type and amount of impurity present in the drug/ chemical varies. • In certain drugs a multiple step synthesis procedure is used which produces intermediate compounds • The purification of intermediates is also important, otherwise the impurities present in the intermediate will get incorporated in the final product
  • 10. • Usually side reactions occur during the synthesis. • Impurities of the product side reactions also occur in the substances This may • introduce new impurities due to contamination by reagents and solvents at various • stages of the process as described below a)Reagents employed in the process b)Reagents added to remove other impurities c)Solvents d)Action of solvents and reagents on reaction vessels
  • 11. a)Reagents employed in the manufacturing process: • Soluble alkali in Calcium carbonate arises from sodium carbonate used in the process. • Calcium carbonate is obtained by interaction of a soluble calcium salt and a soluble carbonate and therefore the product will contain traces of soluble alkali, which the washing process has failed to remove. b) Reagents added to remove other impurities: •Potassium bromide contains traces of Barium, which is added in the manufacturing process to remove excess of sulphate.
  • 12. C) Solvents: Water is the cheapest solvent available and has been used wherever possible. • Tap Water: It has Ca+2, Mg+2, Na+, Cl-, SO4 -2 and CO3 -2 as impurities in small amounts. Hence even if good deal of washing of final product is done by tap water the final product may still contain traces of such impurities. • Softened water: It is obtained by allowing the tap water to pass through the sodium form of Zeolite which removes divalent cations like Ca+2 and Mg+2 from tap water in exchange of sodium. So, softened water contains Na+, Cl- ions as impurity. • De-mineralised water: It is obtained by passing tap water through columns packed with ion exchange resin. The water obtained from this process is free from Ca+2, Mg+2, Na+, Cl-, SO4 -2 and CO3-2. Thus the final product is free from these impurities. The water obtained from this source may still contain organic impurities and so final product contains organic impurities. • Distilled water: It is considered the best but it is very costly.
  • 13. d) Action of solvents and reagents on reaction vessels: • During manufacturing process, some of the solvents and reagent may undergo reaction with metals of reaction vessel and may dissolve these metals, which appear as impurities in the final product. • Example: Iron is known to contain Arsenic impurity. • The inorganic compounds manufactured in Iron vessel will contain Arsenic and Iron as impurities. • Thus IP has prescribed limit test for Arsenic and Iron for most inorganic compounds.
  • 14. 4) Chemical process used in the manufacture: For the synthesis of drugs, many chemical reactions such as Nitration, Halogenation, Oxidation, reduction, hydrolysis are involved. • In these chemical processes, different chemicals are used. • Tap water is generally used in the various processes and it is often having Cl-,Mg+2, Ca+2 ions, which are generally found in the substance which is being manufactured and limit of these impurities have been prescribed in large number of cases. For instance, potassium iodide is manufactured from iodine which is obtained from ‘kelp, a seaweed cyanides tend to get formed when nitrogenous organic matter is burnt with alkalies. Limit tests have been prescribed for cyanides in potassium iodide.
  • 15. 5) Atmospheric contamination during the manufacturing process • In the industrial areas, the atmosphere is contaminated with dust particles and some gases like Hydrogen sulphide, Sulphur dioxide, and black smoke. • During the manufacture or purification of the pharmaceutical products, these impurities enter the final products. • There are many pharmaceutical products which when manufactured are contaminated with atmospheric CO2 and water vapour .E.g NaOH absorbs atmospheric CO2. 2NaOH + CO2 --------------------------------Na2CO3 +H2O • Due to this reaction, NaOH should not be kept open for a longer time during its manufacture. • Therefore, IP has prescribed that Sodium hydroxide should not contain more than 3% of sodium carbonate.
  • 16. 6) Defects in the manufacturing process: • In many manufacturing processes, there are defects like imperfect mixing, incompleteness, non-adherence to proper temperature, pressure, pH or reaction conditions, which may give chemical compounds with impurities in them. Example: • Zinc oxide may be prepared by heating metallic zinc to bright redness in a current of air. The vapours of Zinc burn to form Zinc oxide which is collected as a fine white powder. • But if there is less heat or air or both, zinc metal is not completely converted to zinc oxide. • Thus the final product, Zinc oxide may still contain metallic zinc as impurity. • So, IP has prescribed a test for Zinc metal in zinc oxide.
  • 17. 7) Intermediate products in the manufacturing process: • There are some intermediates which are produced during the manufacturing process. • Sometimes these intermediates may be carried through to the final product as impurity. • Example: • Potassium iodide is prepared by reacting Iodine with Potassium hydroxide. 6KOH+ 3I2--------------------5KI + KIO3 +3H2O • The resulting solution is first evaporated and then heated with charcoal. KIO3 +3C----------KI +3CO • In this process if the intermediate product (KIO3) is not completely converted into KI, then it may be carried through to the final product as an impurity.
  • 18. 8) Manufacturing hazards: Particulate contamination Process errors Cross contamination Microbial contamination Packing error
  • 19. a) Particulate contamination: • The presence of unwanted particulate matter can arise due to dirt, dust, glass, porcelain or plastic fragments from sieves, granulating or tableting machines or from product containers. • Ware and tare of equipment or improperly cleaned equipment may also cause particulate contamination. • Clarity of solutions for injection is particularly important. • E.g Metal particles which have been found in eye ointments packed in metal tubes.
  • 20. b) Process errors: • Gross errors arising from incomplete solution of a solute in a liquid preparation must be detected readily by the normal analytical control procedures. • Minor errors arise if the manufacturing tolerance for the quantity of active ingredient in the product has been wide.
  • 21. c) Cross contamination: • The handling of powders, granules, and tablets in large bulk creates air- borne dust, which leads to cross contamination of theproduct. • So, face masks and special extraction equipment are used to protect operators from harmful effects of drugs. • E.g penicillin preparation requires special handling during itsmanufacture.
  • 22. d) Microbial contamination: • Parenteral preparations and ophthalmic preparations require special care against microbial contamination. • Many liquid preparations and creams are liable to bacterial and fungal contamination. So care should betaken. • Eg. Acacia, senna, tragacanth--- They should be controlled for Salmonellae.
  • 23. e) Packing errors: • Products of similar appearance such as tablets of same size, shape, colour packed in similar containers can constitute a potential source of danger. • Improper labelling or destruction of stock of unused labels also constitutes a major packaging hazard.
  • 24. 9) Storage conditions: • The chemical substances when prepared have to be stored in different types of containers depending upon: • Nature of the material • Batch size • Quantity • Many types of materials are used for storage purpose like plastic, polythene, iron vessels, stainless steel and aluminium. Reaction of these substance + with material of storage vessels-------- The product are found as impurity in stored material.
  • 25. • Leaching out effect: Alkalies stored in ordinary glass containers extract lead from it, which in found as impurity in the final product. • Strong chemicals react with iron containers and extract Iron an impurity in final product.
  • 26. Inadequate storage and their effects are as follows: a)Filth: Stored products may be come contaminated with dust, bodies of insects, animal and insect excreta. b)Chemical instability: decomposition because of light, traces of acid or alkali, air oxidation, water vapour,CO2 and traces of metallic ions. e.g light sensitive materials should be stored in amber colored bottles. c)Reactions with container materials: e.g salicylic acid ointment must not be stored in metal tubes. d)Physical changes: The occurance of changes in the physical form of drug like change in crystal size can lead to change in efficiency ofproduct. e)Temperature effect: Chemical and physical changes occur if materials are not stored at proper temperature.
  • 27. 10) Decomposition of the product during storage: • Some substances decompose on keeping. The decomposition becomes greater in the presence of light-air or oxygen. The result of decomposition bring about contamination of the final product. • Substances which contain water of crystallization lose it on being kept open while deliquescent substances, absorb water from the atmosphere and get liquefied. • Decomposition products appear as impurities in the substances.
  • 28. 11) Accidental substitution or deliberate adulteration with spurious or use less materials: • It is possible to avoid accidental substitution by storing the toxic substances together • Separately or in a locked cupboard. • Many pharmaceutical chemicals are adulterated with cheaper substances. • E.g The expensive potassium may be adulterated with sodium bromide.
  • 29. Effect of Impurities: • The impurities present in the substances may give following effects: • Impurities having toxic effects may be injurious to health, if present above Certain limits. • Traces of impurities, may exert a cumulative toxic effect after a certain time. • Impurities may lower the active strength of the substance. • Impurity may decrease shelf life of substance. • Impurity may cause incompatibility with other substances. • Impurities may cause a physical or chemical change in the properties of the substance, so making the substance medicinally useless. • May cause change in color, odour and taste.
  • 30.  Test for purity: Pharmacopoeia prescribes the “Test for purity” for pharmaceutical substances to check their freedom from undesirable impurities. Pharmacopoeia will decide and fix the limit of tolerance for these impurities. For certain common impurities for which pharmacopoeia prescribes the test of purity are: Colour, odour, taste Physicochemical constants (Iodine value, saponification value, melting point, refractive index etc.) Acidity, alkalinity, pH Humidity (Estimation of moisture) Cations and anions Insoluble Constituent or Residue. Ash, Water insoluble ash Arsenic or lead Loss on drying Loss on ignition